Unbiased AI-powered news
A Chinese court sentenced former defense ministers Wei Fenghe and Li Shangfu to death with a two-year reprieve on bribery charges. The sentences are expected to be commuted to life imprisonment without parole after the reprieve period. The case forms part of a broader series of purges in the country's top military leadership.
A Chinese court has sentenced former defense ministers Wei Fenghe and Li Shangfu to death with a two-year reprieve after convicting them of bribery, according to state media reports cited across multiple outlets. The suspended death sentences mean that if the two-year period passes without further infractions, the sentences are typically commuted to life imprisonment.
Both men were found to have accepted and offered bribes during their tenures, though initial reports did not disclose specific amounts or details of the schemes.
Wei Fenghe served as defense minister from 2018 until 2023. Li Shangfu held the post from 2023 until his removal amid the investigation. The sentencing was reported by state media on Thursday. The court proceedings followed their earlier arrests on the corruption allegations. No further details on additional charges or co-conspirators were released in the initial announcements.
Chinese officials have described the cases as part of an ongoing anti-graft effort, with emphasis that no one is above accountability. The sentencing formula matches that applied in several other recent high-profile corruption cases involving senior military figures. The announcements were confirmed across international news outlets.
These outlets didn't split into competing frames — coverage was uniform.
A 26-year-old Colombian national was fatally shot in Biddeford on Monday. The incident prompted federal officials to suspend most vehicle stops nationwide after two recent deaths.
Al JazeeraSix officers were buried at al-Shifa Hospital in Gaza City on July 14. The death toll since the October ceasefire reached 1,108, with cumulative figures since 2023 at 73,231 killed.
Japan TimesThe University of Oxford has started an early-stage clinical trial of a vaccine targeting the Bundibugyo strain of Ebola. The trial will enroll 50 healthy adults to test safety and immune response.